

Author: Chung D.
Publisher: Elsevier
ISSN: 1471-4914
Source: Trends in Molecular Medicine, Vol.8, Iss.4, 2002-04, pp. : 10-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Immunomodulation in cancer therapeutics
By Ehrke M.J.
International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. :






RAS inhibitors: potential for cancer therapeutics
Molecular Medicine Today, Vol. 6, Iss. 10, 2000-10 ,pp. :


Translating basic cancer research into new cancer therapeutics
Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. :